Dr. Claudia C. Serrano-Gomez, MD

Dr. Serrano-Gomez practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Serrano-Gomez's NPI, 1427273762, was assigned on April 13, 2007. Dr. Serrano-Gomez holds New York license 255071.

Dr. Serrano-Gomez's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Serrano-Gomez's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Serrano-Gomez is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Serrano-Gomez to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serrano-Gomez practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Serrano-Gomez's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Serrano-Gomez is licensed in New York.

CMS data shows 676 Medicare services from Dr. Serrano-Gomez across 10 procedure codes in 2024, for 222 Medicare patients. Medicare paid $74,688 for them.

CMS counts 222 Medicare patients who saw Dr. Serrano-Gomez in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Serrano-Gomez's median patient age at 69, with 57% women.

In 2024, Dr. Serrano-Gomez wrote 7,038 Medicare Part D claims for 806 patients. 78% of them were for generic drugs. CMS names the drug for 6,772 of them, across 66 drugs with 11 or more claims each, at $1,626,288 in total drug cost. In 2023, CMS named 6,928 claims across 63 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Serrano-Gomez for performance year 2024, reported as part of a group. Dr. Serrano-Gomez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Serrano-Gomez as offering telehealth. CMS counts 85 procedures of coronary angioplasty and stenting by Dr. Serrano-Gomez, more than 95% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Serrano-Gomez, published from 2016 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Coronary Angiography, Coronary Vessels and Cardiac Catheterization. Dr. Serrano-Gomez's most frequent co-authors are Nathaniel Rosso Smilowitz, MD, Ayman E. Farid, MD and Michael Attubato, MD.

Dmand AI links Dr. Serrano-Gomez to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease and Coronary Disease.

CMS Open Payments shows 764 general payments to Dr. Serrano-Gomez from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. AstraZeneca Pharmaceuticals LP paid the most, $80,368.